Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gibbs

Showing results (341-350 of 393) with videos related to

Pageof 40
Sort By:
Pulmonary Circulation|May 11, 2013
Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertensionLuke S G E Howard, Geoffrey M J Watson, John Wharton, et al.
American Journal of Respiratory and Critical Care Medicine|February 23, 2008
Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertensionRobin Condliffe, David G Kiely, J Simon R Gibbs, et al.
Circulation|February 8, 2014
Aberrant chloride intracellular channel 4 expression contributes to endothelial dysfunction in pulmonary arterial hypertensionBeata Wojciak-Stothard, Vahitha B Abdul-Salam, Ka Hou Lao, et al.
American Journal of Respiratory and Critical Care Medicine|March 4, 2025
Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in <i>BMPR2</i> Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR)David Montani, Vallerie V McLaughlin, J Simon R Gibbs, et al.
Pulmonary Circulation|April 15, 2020
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?Andrew J Peacock, Yi Ling, Martin K Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and IrelandYi Ling, Martin K Johnson, David G Kiely, et al.
Emergency Medicine Australasia : EMA|November 25, 2015
Best-practice pain management in the emergency department: A cluster-randomised, controlled, intervention trialDavid McD Taylor, Daniel M Fatovich, Daniel P Finucci, et al.
The European Respiratory Journal|September 11, 2023
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trialRogerio Souza, David B Badesch, H Ardeschir Ghofrani, et al.
Circulation|August 1, 2013
Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatmentsLan Zhao, Ali Ashek, Lei Wang, et al.
American Journal of Respiratory and Critical Care Medicine|December 11, 2012
Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertensionChristopher J Rhodes, John Wharton, Reinier A Boon, et al.
Pageof 40

Showing results (341-350 of 393) with videos related to

Sort By:
Pageof 40
Pulmonary Circulation|May 11, 2013
Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertensionLuke S G E Howard, Geoffrey M J Watson, John Wharton, et al.
American Journal of Respiratory and Critical Care Medicine|February 23, 2008
Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertensionRobin Condliffe, David G Kiely, J Simon R Gibbs, et al.
Circulation|February 8, 2014
Aberrant chloride intracellular channel 4 expression contributes to endothelial dysfunction in pulmonary arterial hypertensionBeata Wojciak-Stothard, Vahitha B Abdul-Salam, Ka Hou Lao, et al.
American Journal of Respiratory and Critical Care Medicine|March 4, 2025
Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in <i>BMPR2</i> Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR)David Montani, Vallerie V McLaughlin, J Simon R Gibbs, et al.
Pulmonary Circulation|April 15, 2020
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?Andrew J Peacock, Yi Ling, Martin K Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and IrelandYi Ling, Martin K Johnson, David G Kiely, et al.
Emergency Medicine Australasia : EMA|November 25, 2015
Best-practice pain management in the emergency department: A cluster-randomised, controlled, intervention trialDavid McD Taylor, Daniel M Fatovich, Daniel P Finucci, et al.
The European Respiratory Journal|September 11, 2023
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trialRogerio Souza, David B Badesch, H Ardeschir Ghofrani, et al.
Circulation|August 1, 2013
Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatmentsLan Zhao, Ali Ashek, Lei Wang, et al.
American Journal of Respiratory and Critical Care Medicine|December 11, 2012
Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertensionChristopher J Rhodes, John Wharton, Reinier A Boon, et al.
Pageof 40